ATYR logo

ATyr Pharma (ATYR) Cash From Operations

Annual CFO

-$33.22 M
+$8.66 M+20.69%

December 31, 2023

Summary

Performance

1-Year Change

+20.69%

3-Year Change

-117.12%

5-Year Change

-6.95%

15-Year Change

+21.58%

ATYR Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

36.33%
ATYR annual cash flow from operations is higher than 36.33% of companies in Healthcare sector

High & Low

All-time High

-$15.30 M

3-Year Low

-$41.89 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
ATYR previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Mar 14, 2025
ATYR next annual earnings announcement is scheduled for Mar 14, 2025

OtherATYRcash flowmetrics:

Annual CFI

-$20.13 M
ATYR annual cash flow from investing activities is -$20.13 million

Annual CFF

$66.23 M
ATYR annual cash flow from financing activities is $66.23 million

Annual FCF

-$37.44 M
ATYR annual free cash flow is -$37.44 million

Annual CAPEX

$4.21 M
ATYR annual capital expenditures is $4.21 million

Quarterly CFO

-$13.16 M
+$7.29 M+35.65%

September 1, 2024

Summary

Performance

3-Month Change

+35.65%

1-Year Change

+35.65%

3-Year Change

-26.9%

5-Year Change

-26.9%

ATYR Quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

26.72%
ATYR quarterly cash flow from operations is higher than 26.72% of companies in Healthcare sector

High & Low

All-time High

$2.06 M
ATYR quarterly cash flow from operations is currently -739.36% below its historical high of $2.06 million

3-Year Low

-$22.38 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2024
ATYR previous earnings announcement was published on Sep 1, 2024

Next Quarterly Earnings Report Date

Mar 14, 2025
ATYR next earnings announcement is scheduled for Mar 14, 2025

OtherATYRcash flowmetrics:

Quarterly CFI

$17.95 M
ATYR quarterly cash flow from investing activities is $17.95 million

Quarterly CFF

-$105.00 K
ATYR quarterly cash flow from financing activities is -$105.00 thousand

Quarterly FCF

-$13.17 M
ATYR quarterly free cash flow is -$13.17 million

Quarterly CAPEX

-
ATYR quarterly capital expenditures value is unknown

TTM CFO

-$67.05 M
-$3.60 M-5.67%

September 1, 2024

Summary

Performance

3-Month Change

-5.67%

1-Year Change

-5.67%

3-Year Change

-60.07%

5-Year Change

-60.07%

ATYR TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

22.97%
ATYR TTM cash flow from operations is higher than 22.97% of companies in Healthcare sector

High & Low

All-time High

-$6.34 M

3-Year Low

-$67.05 M
ATYR TTM cash flow from operations is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2024
ATYR previous earnings announcement was published on Sep 1, 2024

Next Quarterly Earnings Report Date

Mar 14, 2025
ATYR next earnings announcement is scheduled for Mar 14, 2025

OtherATYRcash flowmetrics:

TTM CFI

$41.14 M
ATYR TTM cash flow from investing activities is $41.14 million

TTM CFF

$27.06 M
ATYR TTM cash flow from financing activities is $27.06 million

TTM FCF

-$67.11 M
ATYR TTM free cash flow is -$67.11 million

TTM CAPEX

-
ATYR TTM capital expenditures value is unknown

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

ATYR Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+20.7%+35.6%-5.7%
3 y3 years-117.1%-26.9%-60.1%
5 y5 years-7.0%-26.9%-60.1%

ATYR Cash From Operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-0.4%+20.7%-2130.2%+41.2%-107.2%at low
5 y5-year-117.1%+20.7%-739.4%+41.2%-461.9%at low
alltimeall time-117.1%+37.1%-739.4%+41.2%-956.7%at low

ATyr Pharma Cash From Operations History

DateAnnualQuarterlyTTM
Sep 2024
-
-$13.16 M(-35.7%)
-$67.05 M(+5.7%)
Jun 2024
-
-$20.45 M(-8.6%)
-$63.45 M(+15.3%)
Mar 2024
-
-$22.38 M(+102.3%)
-$55.01 M(+65.6%)
Dec 2023
-$33.22 M(-20.7%)
-$11.06 M(+15.7%)
-$33.22 M(+2.1%)
Sep 2023
-
-$9.56 M(-20.4%)
-$32.53 M(-7.7%)
Jun 2023
-
-$12.01 M(+1935.6%)
-$35.25 M(+8.9%)
Mar 2023
-
-$590.00 K(-94.3%)
-$32.36 M(-22.7%)
Dec 2022
-$41.89 M(+26.6%)
-
-
Dec 2022
-
-$10.37 M(-15.6%)
-$41.89 M(+5.8%)
Sep 2022
-
-$12.28 M(+34.7%)
-$39.60 M(+2.1%)
Jun 2022
-
-$9.12 M(-9.9%)
-$38.79 M(+3.8%)
Mar 2022
-
-$10.12 M(+25.1%)
-$37.37 M(+13.0%)
Dec 2021
-$33.08 M(+116.2%)
-$8.09 M(-29.5%)
-$33.08 M(+8.8%)
Sep 2021
-
-$11.47 M(+49.1%)
-$30.39 M(+24.2%)
Jun 2021
-
-$7.69 M(+32.0%)
-$24.48 M(+5.6%)
Mar 2021
-
-$5.83 M(+7.9%)
-$23.19 M(+51.5%)
Dec 2020
-$15.30 M(-23.5%)
-$5.40 M(-2.8%)
-$15.30 M(+3.3%)
Sep 2020
-
-$5.55 M(-13.2%)
-$14.82 M(+9.6%)
Jun 2020
-
-$6.40 M(-411.1%)
-$13.51 M(+13.3%)
Mar 2020
-
$2.06 M(-141.9%)
-$11.93 M(-40.4%)
Dec 2019
-$20.01 M
-$4.92 M(+15.6%)
-$20.01 M(+0.4%)
Sep 2019
-
-$4.25 M(-11.8%)
-$19.94 M(-10.0%)
DateAnnualQuarterlyTTM
Jun 2019
-
-$4.82 M(-20.0%)
-$22.14 M(-16.5%)
Mar 2019
-
-$6.02 M(+24.5%)
-$26.51 M(-14.7%)
Dec 2018
-$31.06 M(-26.7%)
-$4.84 M(-25.1%)
-$31.06 M(-15.0%)
Sep 2018
-
-$6.46 M(-29.7%)
-$36.53 M(-6.2%)
Jun 2018
-
-$9.19 M(-13.1%)
-$38.96 M(-0.2%)
Mar 2018
-
-$10.58 M(+2.6%)
-$39.05 M(-7.8%)
Dec 2017
-$42.36 M(-19.9%)
-$10.31 M(+15.9%)
-$42.36 M(-3.2%)
Sep 2017
-
-$8.89 M(-4.1%)
-$43.75 M(-11.7%)
Jun 2017
-
-$9.28 M(-33.2%)
-$49.55 M(-8.7%)
Mar 2017
-
-$13.89 M(+18.8%)
-$54.26 M(+2.6%)
Dec 2016
-$52.86 M(+43.7%)
-$11.70 M(-20.4%)
-$52.86 M(+3.6%)
Sep 2016
-
-$14.69 M(+5.0%)
-$51.00 M(+11.4%)
Jun 2016
-
-$13.99 M(+12.0%)
-$45.78 M(+6.5%)
Mar 2016
-
-$12.49 M(+27.0%)
-$43.00 M(+16.9%)
Dec 2015
-$36.80 M(+61.2%)
-$9.84 M(+3.9%)
-$36.80 M(+12.3%)
Sep 2015
-
-$9.47 M(-15.5%)
-$32.76 M(+12.7%)
Jun 2015
-
-$11.21 M(+78.3%)
-$29.07 M(+27.7%)
Mar 2015
-
-$6.29 M(+8.4%)
-$22.77 M(-0.3%)
Dec 2014
-$22.82 M(+31.8%)
-$5.80 M(+0.4%)
-$22.82 M(+34.1%)
Sep 2014
-
-$5.78 M(+17.9%)
-$17.02 M(+51.4%)
Jun 2014
-
-$4.90 M(-22.8%)
-$11.24 M(+77.2%)
Mar 2014
-
-$6.34 M
-$6.34 M
Dec 2013
-$17.31 M
-
-

FAQ

  • What is aTyr Pharma annual cash flow from operations?
  • What is the all time high annual CFO for aTyr Pharma?
  • What is aTyr Pharma annual CFO year-on-year change?
  • What is aTyr Pharma quarterly cash flow from operations?
  • What is the all time high quarterly CFO for aTyr Pharma?
  • What is aTyr Pharma quarterly CFO year-on-year change?
  • What is aTyr Pharma TTM cash flow from operations?
  • What is the all time high TTM CFO for aTyr Pharma?
  • What is aTyr Pharma TTM CFO year-on-year change?

What is aTyr Pharma annual cash flow from operations?

The current annual CFO of ATYR is -$33.22 M

What is the all time high annual CFO for aTyr Pharma?

aTyr Pharma all-time high annual cash flow from operations is -$15.30 M

What is aTyr Pharma annual CFO year-on-year change?

Over the past year, ATYR annual cash flow from operations has changed by +$8.66 M (+20.69%)

What is aTyr Pharma quarterly cash flow from operations?

The current quarterly CFO of ATYR is -$13.16 M

What is the all time high quarterly CFO for aTyr Pharma?

aTyr Pharma all-time high quarterly cash flow from operations is $2.06 M

What is aTyr Pharma quarterly CFO year-on-year change?

Over the past year, ATYR quarterly cash flow from operations has changed by +$7.29 M (+35.65%)

What is aTyr Pharma TTM cash flow from operations?

The current TTM CFO of ATYR is -$67.05 M

What is the all time high TTM CFO for aTyr Pharma?

aTyr Pharma all-time high TTM cash flow from operations is -$6.34 M

What is aTyr Pharma TTM CFO year-on-year change?

Over the past year, ATYR TTM cash flow from operations has changed by -$3.60 M (-5.67%)